Disrupting adenosine triphosphate metabolism as a therapeutic strategy against lymphatic cancer progression: a review
Immunology Letters · 2026-10 · 281 · 107186
DOI: 10.1016/j.imlet.2026.107186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology Letters, 2026-10. Verfasst von Mohammad Qutub und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India. Electronic address: qutubmalikqm@gmail.…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Neoplasms. Die Arbeit nennt 96 Literaturangaben.
Abstract (Originalsprache)
Adenosine triphosphate (ATP), the universal cellular energy currency, functions as a central regulator of cancer progression beyond its classical bioenergetic role. This review integrates current evidence on how dysregulated ATP metabolism and signaling contribute to lymphatic cancer progression. Cancer cells undergo metabolic reprogramming, including enhanced glycolysis, fatty acid oxidation (FAO), and oxidative phosphorylation, to sustain elevated ATP production required for proliferation, invasion, and metastasis. ATP plays a pivotal role in lymph node metastasis (LNM), where tumor-derived factors reprogram lymphatic endothelial cells to increase FAO-dependent ATP generation, thereby promoting lymphangiogenesis. Extracellular ATP (eATP) further contributes to tumor progression by activating purinergic receptors, which enhance cancer cell migration and invasiveness. Within the tumor microenvironment (TME), eATP exhibits a dual role. As a damage-associated molecular pattern released during immunogenic cell death, it can stimulate anti-tumor immune responses through dendritic cell activation. However, its rapid hydrolysis by ectonucleotidases CD39 and CD73 produces adenosine, leading to immunosuppression, T-cell exhaustion, and the establishment of an immune-evasive niche, particularly in tumor-draining lymph nodes. ATP-dependent mechanisms also underlie chemoresistance, primarily via ATP-binding cassette (ABC) transporters that actively efflux chemotherapeutic agents. Additionally, the overexpression of ATP-related metabolic enzymes and transporters, including ATP synthase and ATP-citrate lyase (ACLY), correlates with advanced disease stage, metastasis, and poor prognosis. Collectively, ATP-driven pathways represent a critical nexus linking metastasis, immune modulation, and therapeutic resistance, offering promising avenues for biomarker development and targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India. Electronic address: qutubmalikqm@gmail.com.
- Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India. Electronic address: tanvipremchandani10@gmail.com.
- Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi 110062, India.
- Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India. Electronic address: aatatode@gmail.com.
- Department of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India. Electronic address: rkm.hamdard@gmail.com.
- Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, Maharashtra, India. Electronic address: jayabtaksande@gmail.com.
Zitieren
APA
Qutub, M., Premchandani, T., Faizan, M., Tatode, A., Khan, R., Taksande, J., Umekar, M., Singh, M., & Sharma, P. (2026). Disrupting adenosine triphosphate metabolism as a therapeutic strategy against lymphatic cancer progression: a review. Immunology Letters, 281, 107186. https://doi.org/10.1016/j.imlet.2026.107186
Vancouver
Qutub M, Premchandani T, Faizan M, Tatode A, Khan R, Taksande J, et al. Disrupting adenosine triphosphate metabolism as a therapeutic strategy against lymphatic cancer progression: a review. Immunology Letters. 2026;281:107186. doi:10.1016/j.imlet.2026.107186
BibTeX
@article{Qutub2026,
author = {Qutub, Mohammad and Premchandani, Tanvi and Faizan, Mohammad and Tatode, Amol and Khan, Rahmuddin and Taksande, Jayshree and Umekar, Milind and Singh, Manvi and Sharma, Preeti},
title = {Disrupting adenosine triphosphate metabolism as a therapeutic strategy against lymphatic cancer progression: a review},
journal = {Immunology Letters},
year = {2026},
volume = {281},
pages = {107186},
doi = {10.1016/j.imlet.2026.107186}
}
EUVIMED